| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | LY-2157299 | CTRPv2 | pan-cancer | AAC | -0.044 | 0.6 |
| mRNA | SNX-2112:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.019 | 0.6 |
| mRNA | CHIR-99021 | GDSC1000 | pan-cancer | AAC | 0.019 | 0.6 |
| mRNA | Roscovitine | GDSC1000 | pan-cancer | AAC | -0.031 | 0.6 |
| mRNA | Midostaurin | GDSC1000 | pan-cancer | AAC | -0.02 | 0.6 |
| mRNA | GDC-0449 | FIMM | pan-cancer | AAC | -0.1 | 0.6 |
| mRNA | Imatinib | GDSC1000 | pan-cancer | AAC | -0.031 | 0.6 |
| mRNA | BRD-K09587429 | CTRPv2 | pan-cancer | AAC | -0.023 | 0.6 |
| mRNA | BRD-K29086754 | CTRPv2 | pan-cancer | AAC | -0.043 | 0.6 |
| mRNA | chlorambucil | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |